54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
00:32 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Ami Fadia ★★★☆☆ #2084 | Buy | $236.00→ $240.00+1.7% |
|
Aug 07
00:32 UTC
|
RUN
Sunrun
|
◎ Target | Jeff Osborne ★☆☆☆☆ #3040 | Buy | $21.00→ $16.00-23.8% |
|
Aug 07
00:32 UTC
|
RUN
Sunrun
|
◎ Target | Brian Lee not yet tracked | Buy | $18.00→ $15.00-16.7% |
|
Aug 07
00:32 UTC
|
RUN
Sunrun
|
◎ Target | Christopher Dendrinos not yet tracked | Outperform | $18.00→ $14.00-22.2% |
|
Aug 07
00:32 UTC
|
RRX
Regal Rexnord
|
◎ Target | Jeffrey Hammond ★★☆☆☆ #2757 | Overweight | $265.00→ $240.00-9.4% |
|
Aug 07
00:32 UTC
|
ROOT
Root
|
◎ Target | Thomas McJoynt-Griffith not yet tracked | Outperform | $95.00→ $80.00-15.8% |
|
Aug 07
00:32 UTC
|
RL
Ralph Lauren
|
◎ Target | Tom Nikic ★★★★☆ #423 | Buy | $405.00→ $450.00+11.1% |
|
Aug 07
00:32 UTC
|
RELY
Remitly Global
|
◎ Target | Alex Markgraff ★★☆☆☆ #2796 | Overweight | $28.00→ $33.00+17.9% |
|
Aug 07
00:32 UTC
|
RELY
Remitly Global
|
◎ Target | David M. Scharf not yet tracked | Market Outperform | $30.00→ $32.00+6.7% |
|
Aug 07
00:32 UTC
|
REI.UN
RioCan Real Estate Investment Trust
|
◎ Target | firm only | Buy | C$24.00→ C$25.00+4.2% |
|
Aug 07
00:32 UTC
|
REI.UN
RioCan Real Estate Investment Trust
|
◎ Target | firm only | Hold | C$21.50→ C$22.50+4.7% |
|
Aug 07
00:32 UTC
|
REI.UN
RioCan Real Estate Investment Trust
|
◎ Target | firm only | Sec→ r Perform | C$22.25→ C$22.50+1.1% |
|
Aug 07
00:32 UTC
|
REAX
Real Brokerage
|
◎ Target | Matthew Erdner ★★★☆☆ #1468 | Buy | $5.00→ $4.00-20.0% |
|
Aug 07
00:32 UTC
|
RCUS
Arcus Biosciences
|
◎ Target | Robert Driscoll ★★☆☆☆ #2344 | Outperform | $41.00→ $43.00+4.9% |
|
Aug 07
00:32 UTC
|
RCUS
Arcus Biosciences
|
◎ Target | Eva Fortea Verdejo ★★★★☆ #917 | Equal Weight | $23.00→ $26.00+13.0% |
|
Aug 07
00:32 UTC
|
PTRN
Pattern Group
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $24.00→ $29.00+20.8% |
|
Aug 07
00:32 UTC
|
PTGX
Protagonist Therapeutics
|
◎ Target | Geoff Meacham ★★★☆☆ #1436 | Buy | $130.00→ $175.00+34.6% |
|
Aug 07
00:32 UTC
|
PTGX
Protagonist Therapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #1072 | Overweight | $151.00→ $153.00+1.3% |
|
Aug 07
00:32 UTC
|
PSX
Phillips 66
|
◎ Target | Sam Margolin ★★★★☆ #754 | Overweight | $201.00→ $239.00+18.9% |
|
Aug 07
00:32 UTC
|
PSX
Phillips 66
|
◎ Target | Theresa Chen ★★★☆☆ #1737 | Equal Weight | $183.00→ $216.00+18.0% |
|
Aug 07
00:32 UTC
|
PSX
Phillips 66
|
◎ Target | Jason Gabelman ★★★★☆ #522 | Buy | $240.00→ $255.00+6.2% |
|
Aug 07
00:32 UTC
|
PRMB
Primo Brands
|
◎ Target | firm only | Buy | $29.00→ $35.00+20.7% |
|
Aug 07
00:32 UTC
|
PRIM
Primoris Services
|
◎ Target | Joseph Osha ★☆☆☆☆ #3189 | Buy | $162.00→ $127.00-21.6% |
|
Aug 07
00:32 UTC
|
PRAX
Praxis Precision Medicines
|
◎ Target | Ami Fadia ★★★☆☆ #2084 | Buy | $575.00→ $582.00+1.2% |
|
Aug 07
00:32 UTC
|
POWI
Power Integrations
|
◎ Target | Tore Svanberg ★★☆☆☆ #2789 | Buy | $95.00→ $80.00-15.8% |
|
Aug 07
00:32 UTC
|
POWI
Power Integrations
|
◎ Target | David Williams ★☆☆☆☆ #3023 | Buy | $90.00→ $80.00-11.1% |
|
Aug 07
00:32 UTC
|
POLR
Polar Capital
|
◎ Target | firm only | Buy | GBX 1,200→ GBX 1,100-8.3% |
|
Aug 07
00:32 UTC
|
PODD
Insulet
|
◎ Target | Bruce D. Jackson not yet tracked | Buy | $250.00→ $185.00-26.0% |
|
Aug 07
00:32 UTC
|
PODD
Insulet
|
◎ Target | Jonathan Block ★★★☆☆ #1009 | Buy | $225.00→ $180.00-20.0% |
|
Aug 07
00:32 UTC
|
PODD
Insulet
|
◎ Target | William Plovanic ★★★★☆ #580 | Buy | $249.00→ $179.00-28.1% |
|
Aug 07
00:32 UTC
|
PODD
Insulet
|
◎ Target | Patrick Wood ★★★☆☆ #2229 | Neutral | $174.00→ $150.00-13.8% |
|
Aug 07
00:32 UTC
|
PODD
Insulet
|
◎ Target | Mathew Blackman ★★★★☆ #602 | Hold | $294.00→ $144.00-51.0% |
|
Aug 07
00:32 UTC
|
PODD
Insulet
|
◎ Target | Lee Hambright ★★★★☆ #609 | Outperform | $200.00→ $175.00-12.5% |
|
Aug 07
00:32 UTC
|
PODD
Insulet
|
◎ Target | Shagun Singh not yet tracked | Outperform | $245.00→ $160.00-34.7% |
|
Aug 07
00:32 UTC
|
PINS
Pinterest
|
◎ Target | Alec Brondolo ★★★☆☆ #1228 | Overweight | $30.00→ $31.00+3.3% |
|
Aug 07
00:32 UTC
|
PAYS
Paysign
|
◎ Target | Peter Heckmann ★★★★★ #118 | Buy | $9.00→ $12.00+33.3% |
|
Aug 07
00:32 UTC
|
PAYC
Paycom Software
|
◎ Target | Allan Verkhovski ★★★☆☆ #1363 | Buy | $160.00→ $230.00+43.8% |
|
Aug 07
00:32 UTC
|
PAYC
Paycom Software
|
◎ Target | firm only | Market Perform | $145.00→ $208.00+43.4% |
|
Aug 07
00:32 UTC
|
PAYC
Paycom Software
|
◎ Target | Matthew VanVliet ★★★★★ #215 | Neutral | $135.00→ $195.00+44.4% |
|
Aug 07
00:32 UTC
|
PAYC
Paycom Software
|
◎ Target | Brad Reback ★★★☆☆ #1326 | Hold | $120.00→ $200.00+66.7% |
|
Aug 07
00:32 UTC
|
PAYC
Paycom Software
|
◎ Target | Raimo Lenschow ★★★★☆ #661 | Equal Weight | $154.00→ $210.00+36.4% |
|
Aug 07
00:32 UTC
|
PAYC
Paycom Software
|
◎ Target | Jason Celino ★★★★☆ #371 | Overweight | $195.00→ $270.00+38.5% |
|
Aug 07
00:32 UTC
|
PAYC
Paycom Software
|
◎ Target | Jacob Smith not yet tracked | Buy | $180.00→ $225.00+25.0% |
|
Aug 07
00:32 UTC
|
PAYC
Paycom Software
|
◎ Target | Jared Levine ★★★★★ #88 | Buy | $149.00→ $244.00+63.8% |
|
Aug 07
00:32 UTC
|
PAYC
Paycom Software
|
◎ Target | Kevin McVeigh ★★★★☆ #511 | Buy | $195.00→ $205.00+5.1% |
|
Aug 07
00:32 UTC
|
PACS
PACS Group
|
◎ Target | Ben Hendrix ★★★★☆ #740 | Outperform | $52.00→ $57.00+9.6% |
|
Aug 07
00:32 UTC
|
PACS
PACS Group
|
◎ Target | A.J. Rice ★★★★☆ #448 | Buy | $57.00→ $60.00+5.3% |
|
Aug 07
00:32 UTC
|
PACS
PACS Group
|
◎ Target | David MacDonald not yet tracked | Buy | $52.00→ $62.00+19.2% |
|
Aug 07
00:32 UTC
|
OXY
Occidental Petroleum
|
◎ Target | Betty Jiang ★★★☆☆ #1535 | Overweight | $72.00→ $75.00+4.2% |
|
Aug 07
00:32 UTC
|
OUT
OUTFRONT Media
|
◎ Target | Daniel Osley not yet tracked | Overweight | $35.00→ $38.00+8.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.